Positive high-level results from a prespecified interim analysis of the I CAN Phase III trial showed that Ultomiris (ravulizumab) met its primary ...

Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the ...

Ultomiris is a brand-name biologic medication prescribed for certain rare autoimmune disorders. Dosing of Ultomiris is done via intravenous (IV) infusions administered by a healthcare professional.

C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...

Kuala Lumpur hosts first launch as wellness technology brand expands into Middle East, Central Asia, and Sub-Saharan Africa KUALA LUMPUR, Malaysia, April 8, 2026 /PRNewswire/ -- International wellness ...

Offensive lineman, edge rushers, defensive tackles, cornerbacks and wide receivers highlight the list of Chargers' prospects.

EMPAVELI®(pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada ...

ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly ...

Does the gelatin trick recipe really support Jello weight loss? Discover ingredients, benefits & usage details.

The automaker has contacted suppliers in recent weeks to discuss details of the plan for the compact SUV, which would be a ...